Picture1.png
Genius Group to Participate in MicroCap Rodeo Investor Conference on June 6, 2024
June 06, 2024 09:00 ET | Genius Group Limited
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced that management will...
Picture1.png
Genius Group Announces Updated Investor Presentation and Compliance with NYSE Guidelines on Audit Opinion
June 06, 2024 08:00 ET | Genius Group Limited
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced the issuance of an...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conferences
June 03, 2024 09:00 ET | Recursion Pharmaceuticals
SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Arcutis logo.png
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 03, 2024 08:00 ET | Arcutis Biotherapeutics, Inc.
Arcutis today announced that management will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10-13, 2024.
canoo_logoBLK.png
Canoo Announces Participation in June Investor Conferences
June 03, 2024 07:00 ET | Canoo, Inc.
Canoo will participate in the upcoming Stifel Cross Sector Insight and Sidoti Small Cap investor conferences.
NEW ATAI-Logo_Primary.png
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024 07:00 ET | atai Life Sciences
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental...
Arbutus Biopharma Logo
Arbutus to Participate in Jefferies Global Healthcare Conference
May 29, 2024 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Howard Hughes logo.jpg
Howard Hughes Holdings Inc. to Present at NAREIT REITweek 2024 Investor Conference
May 29, 2024 07:17 ET | Howard Hughes Holdings Inc.
Howard Hughes Chief Financial Officer, Carlos Olea, to present at Nareit REITweek 2024 Investor Conference June 4, 2024.
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
May 28, 2024 08:00 ET | Phathom Pharmaceuticals
FLORHAM PARK, N.J., May 28, 2024 (GLOBE NEWSWIRE) --  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology to Participate in Upcoming Investor Conferences in June
May 28, 2024 07:03 ET | Olema Oncology
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...